Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

This study has been completed.

Study NCT00462215 Information provided by Baxter Healthcare Corporation

First Received: April 17, 2007 Last Updated: March 4, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2010
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)